3Billion

3Billion Current Assets

The Current Assets of 3Billion (394800.KQ) as of Oct 22, 2026 is 340.59 M KRW. In the previous year, Current Assets was 25.85 B KRW — a change of -98.68% (lower).

Current Assets

340.59 MKRW

YoY

-98.68%

Last updated:

Current Assets of 3Billion is 2025 340.59 M KRW. Current Assets of 3Billion was 2024 25.85 B KRW. It decreases by -98.68% lower compared to the previous year.

The 3Billion Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2021
303.70 M KRW
Jan 1, 2022
23.74 B KRW
Jan 1, 2023
17.91 B KRW
Jan 1, 2024
25.85 B KRW
Jan 1, 2025
340.59 M KRW
The 3Billion Current Assets history
YEARCurrent AssetsYoY
340.59 MKRW-98.68%
25.85 BKRW+44.35%
17.91 BKRW-24.58%
23.74 BKRW+7,717.99%
303.70 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

3Billion Stock analysis

What does 3Billion do? 3Billion Inc provides genetic testing services, focusing on rare genetic disease diagnostic testing. The company develops technology to automatically read the pathogenicity of genetic variants in the genome. Its primary products are diagnostic testing services and R&D technology for genetic variants. The target customers are medical institutions and healthcare providers requiring genetic diagnostics. The company operates in the healthcare sector, specifically in genetic diagnostics and research. 3Billion Inc's revenue comes from offering diagnostic testing services to healthcare facilities and licensing its R&D technology. The firm serves medical institutions seeking accurate genetic disease diagnosis and research institutions developing genetic analysis tools. The company's services support both clinical diagnostics and scientific research in genomics. The business model centers on two main revenue streams: direct sales of genetic diagnostic services and technology licensing. Healthcare providers purchase diagnostic testing to identify rare genetic conditions, while research organizations license the automatic pathogenicity reading technology for genomic studies. The company's focus on rare genetic diseases differentiates its offerings in the medical diagnostics market. 3Billion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about 3Billion stock

Current Assets of 3Billion is 340.59 M KRW in 2025.

Current Assets of 3Billion changed from 25.85 B KRW to 340.59 M KRW, representing a -98.68% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets 3Billion since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's 3Billion historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — 3Billion

All Key Metrics — 3Billion